Navigated to Tomorrow: GLP-1 Costs, Billing and Commitment
Skip to main content
GLP1 Buyer Guide
All ranked programsProvider profile
Compounded products2 recorded medications

Tomorrow

Tomorrow is recorded on 8 offers in this comparison, covering semaglutide, tirzepatide. Each plan is recorded separately with its own charge, cadence and commitment.

By Open Water Rx Editorial Team, Publisher and buyer-guide research

Price sources checked
Buyer Guide ScoreMethod
77.2/100
Strong

Ranked 20 of 67 programs in the buyer guide index.

Price93/100
Fee transparency50/100
Cadence certainty100/100
Terms on record100/100

Each criterion is rated on its own out of 100. The headline score is the publisher’s overall judgment; it is not an average of these four readings.

Tirzepatide
$299Lowest of 4 recorded plans
Semaglutide
$199Lowest of 4 recorded plans
Membership
Not statedNot stated on the provider page
Commitment
Auto-renewsThe term recorded on the plan

Supported tradeoffs

Published program bundle, not a verified patient-specific checkout total. Injection and sublingual preparations must remain separate comparison groups.

Billing and cancellation

Injection and sublingual plans list semaglutide $199 monthly or $549 quarterly; tirzepatide $299 monthly or $819 quarterly. Plans renew at the selected interval.

Availability

The supported-state list is not established for this program, so the field is left blank rather than assumed.

Availability is set program by program by prescriber licensure, pharmacy fulfillment and state rules, so it can change after a directory is published. A provider state directory is not a fulfillment guarantee, and where a supported-state list is not established the field is left blank rather than assumed.

Offer terms in detail

Every field the record carries for each plan, with the date the provider page behind it was checked.

SemaglutideCompounded · not FDA-approved

1-month plan

7 recorded source entries · last checked October 22, 2026.

Recurring charge

$199

Recurring

Formulation
Compounded injectable
Initial payment
$199 · No medication charge unless provider-approved.
Billing cadence
Recurring
Supply period
Not established from reviewed sources.
Commitment
Auto-renews on the recorded billing cadence until canceled. Each charge covers 1 month as published. The minimum term is not established from the reviewed terms; the cancellation conditions are recorded on this offer.
Required fees
Conditional: Policy reserves applicable tax and any shipping/service fees disclosed at checkout; no universal additional amount is established.
Conditional fees
Policy reserves applicable tax and any shipping/service fees disclosed at checkout; no universal additional amount is established.
Inclusions
Medication, consultation, ongoing clinical support and shipping in the advertised program.
Dose scope
Provider-selected; numeric range not established
Eligibility
Subject to provider approval and availability
Cancellation
Cancel through the account or [email protected] at least three days before billing. Cancelling renewal does not withdraw an order already submitted for clinical review.
Refunds
Not charged if clinically declined. Submitted clinical-review orders cannot be voluntarily withdrawn. Processed/shipped prescriptions are final sale; discretionary exceptions such as duplicate charges are reviewed individually. No partial-period refund.
Limitations
Published program bundle, not a verified patient-specific checkout total. Injection and sublingual preparations must remain separate comparison groups.
Offers excluded from this release
[]
Verification
published price and billing terms · recheck due October 29, 2026
SemaglutideCompounded · not FDA-approved

3-month plan

7 recorded source entries · last checked October 22, 2026.

Recurring charge

$549

Recurring

Formulation
Compounded injectable
Initial payment
$549 · No medication charge unless provider-approved.
Billing cadence
Recurring
Supply period
Not established from reviewed sources.
Commitment
Auto-renews on the recorded billing cadence until canceled. Each charge covers 3 months as published. The minimum term is not established from the reviewed terms; the cancellation conditions are recorded on this offer.
Required fees
Conditional: Policy reserves applicable tax and any shipping/service fees disclosed at checkout; no universal additional amount is established.
Conditional fees
Policy reserves applicable tax and any shipping/service fees disclosed at checkout; no universal additional amount is established.
Inclusions
Medication, consultation, ongoing clinical support and shipping in the advertised program.
Dose scope
Provider-selected; numeric range not established
Eligibility
Subject to provider approval and availability
Cancellation
Cancel through the account or [email protected] at least three days before billing. Cancelling renewal does not withdraw an order already submitted for clinical review.
Refunds
Not charged if clinically declined. Submitted clinical-review orders cannot be voluntarily withdrawn. Processed/shipped prescriptions are final sale; discretionary exceptions such as duplicate charges are reviewed individually. No partial-period refund.
Verification
published price and billing terms · recheck due October 29, 2026
SemaglutideCompounded · not FDA-approved

1-month plan

7 recorded source entries · last checked October 22, 2026.

Recurring charge

$199

Recurring

Formulation
Compounded sublingual
Initial payment
$199 · No medication charge unless provider-approved.
Billing cadence
Recurring
Supply period
Not established from reviewed sources.
Commitment
Auto-renews on the recorded billing cadence until canceled. Each charge covers 1 month as published. The minimum term is not established from the reviewed terms; the cancellation conditions are recorded on this offer.
Required fees
Conditional: Policy reserves applicable tax and any shipping/service fees disclosed at checkout; no universal additional amount is established.
Conditional fees
Policy reserves applicable tax and any shipping/service fees disclosed at checkout; no universal additional amount is established.
Inclusions
Medication, consultation, ongoing clinical support and shipping in the advertised program.
Dose scope
Provider-selected; numeric range not established
Eligibility
Subject to provider approval and availability
Cancellation
Cancel through the account or [email protected] at least three days before billing. Cancelling renewal does not withdraw an order already submitted for clinical review.
Refunds
Not charged if clinically declined. Submitted clinical-review orders cannot be voluntarily withdrawn. Processed/shipped prescriptions are final sale; discretionary exceptions such as duplicate charges are reviewed individually. No partial-period refund.
Verification
published price and billing terms · recheck due October 29, 2026
SemaglutideCompounded · not FDA-approved

3-month plan

7 recorded source entries · last checked October 22, 2026.

Recurring charge

$549

Recurring

Formulation
Compounded sublingual
Initial payment
$549 · No medication charge unless provider-approved.
Billing cadence
Recurring
Supply period
Not established from reviewed sources.
Commitment
Auto-renews on the recorded billing cadence until canceled. Each charge covers 3 months as published. The minimum term is not established from the reviewed terms; the cancellation conditions are recorded on this offer.
Required fees
Conditional: Policy reserves applicable tax and any shipping/service fees disclosed at checkout; no universal additional amount is established.
Conditional fees
Policy reserves applicable tax and any shipping/service fees disclosed at checkout; no universal additional amount is established.
Inclusions
Medication, consultation, ongoing clinical support and shipping in the advertised program.
Dose scope
Provider-selected; numeric range not established
Eligibility
Subject to provider approval and availability
Cancellation
Cancel through the account or [email protected] at least three days before billing. Cancelling renewal does not withdraw an order already submitted for clinical review.
Refunds
Not charged if clinically declined. Submitted clinical-review orders cannot be voluntarily withdrawn. Processed/shipped prescriptions are final sale; discretionary exceptions such as duplicate charges are reviewed individually. No partial-period refund.
Verification
published price and billing terms · recheck due October 29, 2026
TirzepatideCompounded · not FDA-approved

1-month plan

7 recorded source entries · last checked October 22, 2026.

Recurring charge

$299

Recurring

Formulation
Compounded injectable
Initial payment
$299 · No medication charge unless provider-approved.
Billing cadence
Recurring
Supply period
Not established from reviewed sources.
Commitment
Auto-renews on the recorded billing cadence until canceled. Each charge covers 1 month as published. The minimum term is not established from the reviewed terms; the cancellation conditions are recorded on this offer.
Required fees
Conditional: Policy reserves applicable tax and any shipping/service fees disclosed at checkout; no universal additional amount is established.
Conditional fees
Policy reserves applicable tax and any shipping/service fees disclosed at checkout; no universal additional amount is established.
Inclusions
Medication, consultation, ongoing clinical support and shipping in the advertised program.
Dose scope
Provider-selected; numeric range not established
Eligibility
Subject to provider approval and availability
Cancellation
Cancel through the account or [email protected] at least three days before billing. Cancelling renewal does not withdraw an order already submitted for clinical review.
Refunds
Not charged if clinically declined. Submitted clinical-review orders cannot be voluntarily withdrawn. Processed/shipped prescriptions are final sale; discretionary exceptions such as duplicate charges are reviewed individually. No partial-period refund.
Verification
published price and billing terms · recheck due October 29, 2026
TirzepatideCompounded · not FDA-approved

3-month plan

7 recorded source entries · last checked October 22, 2026.

Recurring charge

$819

Recurring

Formulation
Compounded injectable
Initial payment
$819 · No medication charge unless provider-approved.
Billing cadence
Recurring
Supply period
Not established from reviewed sources.
Commitment
Auto-renews on the recorded billing cadence until canceled. Each charge covers 3 months as published. The minimum term is not established from the reviewed terms; the cancellation conditions are recorded on this offer.
Required fees
Conditional: Policy reserves applicable tax and any shipping/service fees disclosed at checkout; no universal additional amount is established.
Conditional fees
Policy reserves applicable tax and any shipping/service fees disclosed at checkout; no universal additional amount is established.
Inclusions
Medication, consultation, ongoing clinical support and shipping in the advertised program.
Dose scope
Provider-selected; numeric range not established
Eligibility
Subject to provider approval and availability
Cancellation
Cancel through the account or [email protected] at least three days before billing. Cancelling renewal does not withdraw an order already submitted for clinical review.
Refunds
Not charged if clinically declined. Submitted clinical-review orders cannot be voluntarily withdrawn. Processed/shipped prescriptions are final sale; discretionary exceptions such as duplicate charges are reviewed individually. No partial-period refund.
Verification
published price and billing terms · recheck due October 29, 2026
TirzepatideCompounded · not FDA-approved

1-month plan

7 recorded source entries · last checked October 22, 2026.

Recurring charge

$299

Recurring

Formulation
Compounded sublingual
Initial payment
$299 · No medication charge unless provider-approved.
Billing cadence
Recurring
Supply period
Not established from reviewed sources.
Commitment
Auto-renews on the recorded billing cadence until canceled. Each charge covers 1 month as published. The minimum term is not established from the reviewed terms; the cancellation conditions are recorded on this offer.
Required fees
Conditional: Policy reserves applicable tax and any shipping/service fees disclosed at checkout; no universal additional amount is established.
Conditional fees
Policy reserves applicable tax and any shipping/service fees disclosed at checkout; no universal additional amount is established.
Inclusions
Medication, consultation, ongoing clinical support and shipping in the advertised program.
Dose scope
Provider-selected; numeric range not established
Eligibility
Subject to provider approval and availability
Cancellation
Cancel through the account or [email protected] at least three days before billing. Cancelling renewal does not withdraw an order already submitted for clinical review.
Refunds
Not charged if clinically declined. Submitted clinical-review orders cannot be voluntarily withdrawn. Processed/shipped prescriptions are final sale; discretionary exceptions such as duplicate charges are reviewed individually. No partial-period refund.
Verification
published price and billing terms · recheck due October 29, 2026
TirzepatideCompounded · not FDA-approved

3-month plan

7 recorded source entries · last checked October 22, 2026.

Recurring charge

$819

Recurring

Formulation
Compounded sublingual
Initial payment
$819 · No medication charge unless provider-approved.
Billing cadence
Recurring
Supply period
Not established from reviewed sources.
Commitment
Auto-renews on the recorded billing cadence until canceled. Each charge covers 3 months as published. The minimum term is not established from the reviewed terms; the cancellation conditions are recorded on this offer.
Required fees
Conditional: Policy reserves applicable tax and any shipping/service fees disclosed at checkout; no universal additional amount is established.
Conditional fees
Policy reserves applicable tax and any shipping/service fees disclosed at checkout; no universal additional amount is established.
Inclusions
Medication, consultation, ongoing clinical support and shipping in the advertised program.
Dose scope
Provider-selected; numeric range not established
Eligibility
Subject to provider approval and availability
Cancellation
Cancel through the account or [email protected] at least three days before billing. Cancelling renewal does not withdraw an order already submitted for clinical review.
Refunds
Not charged if clinically declined. Submitted clinical-review orders cannot be voluntarily withdrawn. Processed/shipped prescriptions are final sale; discretionary exceptions such as duplicate charges are reviewed individually. No partial-period refund.
Verification
published price and billing terms · recheck due October 29, 2026

Cost and verification scope

Semaglutide · Tirzepatide

Published standard plan bundle; conditional charges are described in provider terms

Published pricing and billing terms; no purchase, clinical, licensing or fulfillment audit

Last checked

Most recent check date

October 22, 2026

The newest date we checked Tomorrow's own published pages. A figure we could not check carries no date rather than an unverified one, and this research reads published pages, not checkout transactions.

How sources are checked

Every recorded offer, side by side with the others: the comparison ledger.

Back to the provider directory
FAQ

Questions about Tomorrow

How to read the fields, the sources and the labels on this profile.

  • It means no reliable figure exists yet for that field on this provider, so we leave it blank instead of guessing. A field becomes a published value only when a page on this provider supports it.

Last modified . Facts carry the date we checked the provider page behind them.